Pfizer Pays $55M For Off-Label Promotion Of Wyeth's Protonix
Pfizer Inc. will pay $55 million to settle allegations that Wyeth LLC, which it bought three years ago, illegally promoted heartburn drug Protonix for off-label uses, the U.S. Department of Justice...To view the full article, register now.
Already a subscriber? Click here to view full article